Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |